Lamictal XR lamotrigine regulatory update

FDA extended the PDUFA date to May 28 from Feb. 28 for an NDA from GlaxoSmithKline for Lamictal XR lamotrigine as add-on therapy for partial onset seizures with or without secondary generalization in ...